Hartline Investment Corp Amgen Inc Transaction History

Hartline Investment Corp

$741 Million
Q2 2024

A detailed history of Hartline Investment Corp transactions in Amgen Inc stock. As of the latest transaction made, Hartline Investment Corp holds 2,975 shares of AMGN stock, worth $940,100. This represents 0.13% of its overall portfolio holdings.

Number of Shares

2,975

Previous 11,496 74.12%

Holding current value

$940,100

Previous $3.27 Million 71.57%

% of portfolio

0.13%

Previous 0.59%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$262.75 - $319.31 $2.24 Million - $2.72 Million	-8,521 Reduced 74.12%	2,975 $929,000
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $2.23 Million - $2.69 Million	8,276 Added 257.02%	11,496 $3.27 Million
Q2 2023 Aug 03, 2023	BUY	$214.27 - $253.37 $52,496 - $62,075	245 Added 8.24%	3,220 $714,000
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $442,944 - $562,813	1,934 Added 185.78%	2,975 $781,000
Q3 2022 Nov 01, 2022	SELL	$224.46 - $253.15 $1.88 Million - $2.12 Million	-8,359 Reduced 88.93%	1,041 $235,000
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $45,680 - $50,834	198 Added 2.15%	9,400 $2.29 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $626,673 - $693,265	2,858 Added 45.05%	9,202 $2.23 Million
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $331,731 - $379,636	-1,668 Reduced 20.82%	6,344 $1.43 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $252,601 - $295,953	-1,190 Reduced 12.93%	8,012 $1.7 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $43,938 - $51,202	-198 Reduced 2.11%	9,202 $2.29 Million
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $72,054 - $85,804	-333 Reduced 3.42%	9,400 $2.16 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $341,650 - $379,943	-1,456 Reduced 13.01%	9,733 $2.47 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $21,759 - $26,701	110 Added 0.99%	11,189 $2.64 Million
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $7,654 - $10,151	-42 Reduced 0.38%	11,079 $2.25 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $22,705 - $29,184	-120 Reduced 1.07%	11,121 $2.68 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $15,669 - $18,775	-90 Reduced 0.79%	11,241 $2.18 Million
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $3,000 - $3,517	18 Added 0.16%	11,331 $2.09 Million
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $10,490 - $11,825	58 Added 0.52%	11,313 $2.15 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $73,144 - $85,382	410 Added 3.78%	11,255 $2.19 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $10,746 - $12,115	-58 Reduced 0.53%	10,845 $2.25 Million
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $24,575 - $27,603	148 Added 1.38%	10,903 $2.01 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $2,202 - $2,574	13 Added 0.12%	10,755 $1.83 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $30,382 - $33,946	180 Added 1.7%	10,742 $1.87 Million
Q3 2017 Nov 20, 2017	BUY	$167.29 - $191.0 $1.77 Million - $2.02 Million	10,562	10,562 $1.97 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartline Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hartline Investment Corp with notifications on news.

Account

Hartline Investment Corp Amgen Inc Transaction History